NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113. A total of 34 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $307,000 | – | 127,029 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 260,000 | $629,000 | 0.12% |
| Values First Advisors, Inc. | 42,308 | $102,000 | 0.08% |
| FRAZIER MANAGEMENT LLC | 425,650 | $1,030,000 | 0.08% |
| ABG Innovation Capital Partners III GP Ltd | 45,849 | $111,000 | 0.06% |
| CCG WEALTH MANAGEMENT, LLC | 10,480 | $25,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 50,549 | $122,000 | 0.02% |
| Clear Creek Financial Management, LLC | 20,050 | $48,000 | 0.01% |
| Granahan Investment Management | 127,029 | $307,000 | 0.01% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 35,174 | $88,000 | 0.01% |
| Virtu Financial LLC | 22,060 | $53,000 | 0.01% |